Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Susan
S. Schiffman & Kristina
I. Rother. (2013) Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues. Journal of Toxicology and Environmental Health, Part B 16:7, pages 399-451.
Read now
Read now
Justin D Lutz & Nina Isoherranen. (2012) In vitro-to-in vivo predictions of drug–drug interactions involving multiple reversible inhibitors. Expert Opinion on Drug Metabolism & Toxicology 8:4, pages 449-466.
Read now
Read now
ChristopherS. Mazur, JohnF. Kenneke, Caroline Tebes-Stevens, MilesS. Okino & JohnC. Lipscomb. (2007) In Vitro Metabolism of the Fungicide and Environmental Contaminant trans-bromuconazole and Implications for Risk Assessment. Journal of Toxicology and Environmental Health, Part A 70:14, pages 1241-1250.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
R. J. Weaver. (2001) Assessment of drug-drug interactions: concepts and approaches. Xenobiotica 31:8-9, pages 499-538.
Read now
Read now
Articles from other publishers (20)
Evangelia Eirini Tsermpini, Alessandro Serretti & Vita Dolžan. 2023.
Sang Zhu, Yan Rong & Tony K. L. Kiang. (2021) Effects of p-Cresol on Oxidative Stress, Glutathione Depletion, and Necrosis in HepaRG Cells: Comparisons to Other Uremic Toxins and the Role of p-Cresol Glucuronide Formation. Pharmaceutics 13:6, pages 857.
Crossref
Crossref
Tamas Kriska, Michael J. Thomas, John R. Falck & William B. Campbell. (2018) Deactivation of 12(S)-HETE through (ω-1)-hydroxylation and β-oxidation in alternatively activated macrophages. Journal of Lipid Research 59:4, pages 615-624.
Crossref
Crossref
Viktoriia Burkina, Vladimir Zlabek & Galia Zamaratskaia. (2013) Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout. Chemosphere 92:9, pages 1099-1104.
Crossref
Crossref
Jae Yong Choi, Chul Hoon Kim, Tae Joo Jeon, Byoung Soo Kim, Chi Hoon Yi, Kwang Sun Woo, Young Beom Seo, Sang Jin Han, Kyeong Min Kim, Dae Ik Yi, Minkyung Lee, Dong Goo Kim, Jung Young Kim, Kyo Chul Lee, Tae Hyun Choi, Gwangil An & Young Hoon Ryu. (2012)
Effective MicroPET imaging of brain 5‐HT
1A
receptors in rats with [
18
F]MeFWAY by suppression of radioligand defluorination
. Synapse 66:12, pages 1015-1023.
Crossref
Crossref
David E. Moody. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions
25
116
.
G Merino, A J Molina, J L García, M M Pulido, J G Prieto & A I Alvarez. (2003) Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole. Journal of Pharmacy and Pharmacology 55:6, pages 757-764.
Crossref
Crossref
Hugues Ouellet, Jonathan B. Johnston & Paul R. Ortiz de Montellano. (2010) The Mycobacterium tuberculosis cytochrome P450 system. Archives of Biochemistry and Biophysics 493:1, pages 82-95.
Crossref
Crossref
J. J. Aaron, M. D. Gaye Seye, S. Trajkovska & N. Motohashi. 2009. Bioactive Heterocycles VII. Bioactive Heterocycles VII
153
231
.
Paraskevi Gaganis, John O. Miners & Kathleen M. Knights. (2007) Glucuronidation of fenamates: Kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7. Biochemical Pharmacology 73:10, pages 1683-1691.
Crossref
Crossref
Robert L. Haining & Mari Nichols-Haining. (2007) Cytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?. Pharmacology & Therapeutics 113:3, pages 537-545.
Crossref
Crossref
Toshiro NIWAToshifumi SHIRAGAAkira TAKAGI. (2005) Drug-Drug Interaction of Antifungal Drugs抗真菌剤の薬物相互作用—薬物代謝酵素に及ぼす影響—. YAKUGAKU ZASSHI 125:10, pages 795-805.
Crossref
Crossref
Christian Wolff, Michel Gillard, Bruno Fuks & Pierre Chatelain. (2005) [3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction. European Journal of Pharmacology 518:1, pages 10-17.
Crossref
Crossref
Toshiro NiwaSachiko Inoue-YamamotoToshifumi ShiragaAkira Takagi. (2005) Effect of Antifungal Drugs on Cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 Activities in Human Liver Microsomes. Biological and Pharmaceutical Bulletin 28:9, pages 1813-1816.
Crossref
Crossref
Katalin Monostory, Eszter Hazai & László Vereczkey. (2004) Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chemico-Biological Interactions 147:3, pages 331-340.
Crossref
Crossref
David E. Moody. 2004. Handbook of Drug Interactions. Handbook of Drug Interactions
3
88
.
Bryan D. MarksRonald W. SmithHeidi A. BraunTony A. GoossensMarie ChristensonMary S. OzersConnie S. LebakkenOlga V. Trubetskoy. (2002)
A High Throughput Screening Assay to Screen for CYP2E1 Metabolism and Inhibition Using a Fluorogenic Vivid
®
P450 Substrate
. ASSAY and Drug Development Technologies 1:1, pages 73-81.
Crossref
Crossref
Eszter Hazai, László Vereczkey & Katalin Monostory. (2002) Reduction of Toxic Metabolite Formation of Acetaminophen. Biochemical and Biophysical Research Communications 291:4, pages 1089-1094.
Crossref
Crossref
Chin‐Eng Ong, Sally Coulter, Donald J. Birkett, C. Ramana Bhasker & John O. Miners. (2008) The xenobiotic inhibitor profile of cytochrome P4502C8. British Journal of Clinical Pharmacology 50:6, pages 573-580.
Crossref
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (2000) Effects of the Antifungal Agents on Oxidative Drug Metabolism. Clinical Pharmacokinetics 38:2, pages 111-180.
Crossref
Crossref